EUROLIGHT Study for Photobiomodulation in Dry Age Related Macular degeneration.
This European study will collect real world data from centres that have been undertaking this treatment
in Europe for up to 3 years. Over 16,000 patient have been treated so this study will give some real insight into
how patients have responded in the real world.
A notable comment from Oygunn Uthiem
“We are thrilled to be part of the EUROLIGHT study,” said Oygunn Uthiem, MD, PhD, Norwegian Dry Eye Clinic/Øyehelseklinikken, Department of Medical Biochemistry/Department of Ophthalmology, Oslo University Hospital. “We have treated over 350 patients in the last four years and have seen the real-world benefits of Valeda treatments in our patients. We have started to upload data into the registry database and have obtained over 70 informed consents from patients that want to be part of the study. Our patients have strictly followed the clinical trial protocols and been tested every 4-6 months, some for up to four years.”
https://eu.lumithera.com